Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

Clinical trial NCT06218628 · RECRUITING

Trial details

NCT number: NCT06218628
Sponsor: Fox Chase Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Chronic Myelomonocytic Leukemia Polycythemia Vera Essential Thrombocytosis

Start date: 2024-04-05
Primary completion: 2029-08-22
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.